These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35496793)

  • 1. Generation and application of TGFβ-educated human Vγ9Vδ2 T cells.
    Parente-Pereira AC; Beatson RE; Davies DM; Hull C; Whilding LM; Porter JC; Maher J
    STAR Protoc; 2022 Jun; 3(2):101319. PubMed ID: 35496793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of hypoxia-sensing chimeric antigen receptor T cells.
    Kosti P; Larios-Martinez KI; Maher J; Arnold JN
    STAR Protoc; 2021 Sep; 2(3):100723. PubMed ID: 34401788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation.
    Larcombe-Young D; Whilding L; Davies DM; Draper B; Bechman N; Maher J
    STAR Protoc; 2022 Jun; 3(2):101414. PubMed ID: 35620078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation.
    Ellis GI; Deng MZ; Winn DW; Coker KE; Shukla D; Bhoj V; Milone MC; Duran-Struuck R; Riley JL
    STAR Protoc; 2022 Dec; 3(4):101784. PubMed ID: 36386869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transwell migration assay to interrogate human CAR-T cell chemotaxis.
    Oner A; Kobold S
    STAR Protoc; 2022 Dec; 3(4):101708. PubMed ID: 36136753
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Brakel BA; Chokshi CR; Salim SK; Venugopal C; Singh S
    STAR Protoc; 2021 Dec; 2(4):100920. PubMed ID: 34761232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cells.
    Zhang X; Ang WX; Du Z; Ng YY; Zha S; Chen C; Xiao L; Ng JY; Chng WJ; Wang S
    Immunotherapy; 2022 Apr; 14(5):321-336. PubMed ID: 35152722
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of effector Vγ9Vδ2 T cells and evaluation of their response to phosphoantigen-loaded cells.
    Hsiao CC; Wiemer AJ
    STAR Protoc; 2022 Jun; 3(2):101422. PubMed ID: 35677612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models.
    Li N; Nguyen R; Thiele CJ; Ho M
    STAR Protoc; 2021 Dec; 2(4):100942. PubMed ID: 34825213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of human CAR-NK cells with lentiviral vectors and functional assessment
    Portillo AL; Hogg R; Ashkar AA
    STAR Protoc; 2021 Dec; 2(4):100956. PubMed ID: 34825217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer.
    Rotolo A; Atherton MJ; Kasper BT; Haran KP; Mason NJ
    STAR Protoc; 2021 Dec; 2(4):100905. PubMed ID: 34746864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells.
    Xiao L; Chen C; Li Z; Zhu S; Tay JC; Zhang X; Zha S; Zeng J; Tan WK; Liu X; Chng WJ; Wang S
    Cytotherapy; 2018 Mar; 20(3):420-435. PubMed ID: 29402645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-culture of primary human T cells with leukemia cells to measure regulatory T cell expansion.
    Külp M; Diehl L; Bonig H; Marschalek R
    STAR Protoc; 2022 Sep; 3(3):101661. PubMed ID: 36097388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth.
    Zhang X; Ng YY; Du Z; Li Z; Chen C; Xiao L; Chng WJ; Wang S
    PLoS One; 2022; 17(6):e0267475. PubMed ID: 35709135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity.
    Zhai X; You F; Xiang S; Jiang L; Chen D; Li Y; Fan S; Han Z; Zhang T; An G; Zhang B; Chen Y; Meng H; Yang L
    Am J Cancer Res; 2021; 11(1):79-91. PubMed ID: 33520361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma.
    Tatari N; Maich WT; Salim SK; Mckenna D; Venugopal C; Singh S
    STAR Protoc; 2020 Dec; 1(3):100174. PubMed ID: 33377068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.
    Zhang Z; Jiang J; Wu X; Zhang M; Luo D; Zhang R; Li S; He Y; Bian H; Chen Z
    Front Med; 2019 Feb; 13(1):57-68. PubMed ID: 30721445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.
    Du SH; Li Z; Chen C; Tan WK; Chi Z; Kwang TW; Xu XH; Wang S
    PLoS One; 2016; 11(9):e0161820. PubMed ID: 27598655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
    Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.
    Liu Z; Guo BL; Gehrs BC; Nan L; Lopez RD
    J Urol; 2005 May; 173(5):1552-6. PubMed ID: 15821484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.